Table 1 Characteristics of the 98 MDS patients treated with decitabine
Characteristics | Category |
|---|---|
Median age (range) | 62 (20–82) |
Sex, n (%) | |
Male | 69 (70) |
Female | 29 (30) |
WHO/FAB classification, n (%) | |
RCMD | 19 (20) |
RAS | 2 (3) |
RAEB-1 | 25 (22) |
RAEB-2 | 29 (30) |
RAEB-t | 14 (17) |
CMML | 9 (8) |
Karyotypes, n(%) | |
Normal | 49 (50) |
+8 | 7 (7) |
−7/7q- | 9 (9) |
−5/5q- | 2 (2) |
20q- | 5 (5) |
Complex | 13 (13) |
Others | 13 (13) |
International prognostic scoring system, n (%) | |
Low | 4 (4) |
Intermediate-1 | 33 (34) |
Intermediate-2 | 34 (35) |
High | 27 (27) |